Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aura Biosciences, Inc.

5.80
+0.830016.70%
Post-market: 5.800.00000.00%18:10 EDT
Volume:303.79K
Turnover:1.70M
Market Cap:291.56M
PE:-3.31
High:5.82
Open:4.96
Low:4.95
Close:4.97
Loading ...
Feb 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 02, 2023

Major Issues Report

Form 8-K - Current report